MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

DaVita Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

138.21 -0.76

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

137.18

Max

140.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

135M

349M

Pardavimai

35M

3.3B

P/E

Sektoriaus vid.

12.442

57.333

Pelnas, tenkantis vienai akcijai

2.24

Pelno marža

10.6

Darbuotojai

76,000

EBITDA

8.4M

727M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+23.24% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-3.3B

11B

Ankstesnė atidarymo kaina

138.97

Ankstesnė uždarymo kaina

138.21

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

DaVita Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-14 19:50; UTC

Pagrindinės rinkos jėgos

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

2025-03-21 08:19; UTC

Rinkos pokalbiai

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

2024-07-15 08:17; UTC

Rinkos pokalbiai

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Akcijų palyginimas

Kainos pokytis

DaVita Inc Prognozė

Kainos tikslas

By TipRanks

23.24% į viršų

12 mėnesių prognozė

Vidutinis 172 USD  23.24%

Aukščiausias 184 USD

Žemiausias 165 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines DaVita Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

0

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

134.97 / 141.35Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.